Young W.: Role of calcium in central nervous system injuries. J Neurotrauma1992;9:9-15.
2.
Nowycky MC, Fox AF, Tsien RW: Three types of neuronal calcium channel with different calcium sensitivity . Nature1985;316:440-443.
3.
Pledger GW, Trieman DM: Design of individualized fixed dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration. Controlled Clin Trials1991;12:768-779.
4.
Aluing J., Kristensen O., Tsiropoulos I., et al: Double-blind, placebo-controlled evaluation of flunarizine as adjunct therapy in epilepsy with complex partial seizures. Acta Neurol Scand1989;79:128-132.
5.
Battaglia A. , Ferrari AR, Guerrini R.: Double-blind, placebo-controlled trial of flunarizine as add-on therapy in refractory childhood epilepsy. Brain Dev1991;13:217-222.
6.
Godfraind T. , Miller R., Wibo M.: Calcium antagonism and calcium entry blockade . Pharmacol Rev1986;38:321-416.
7.
Pellock J.: The clinical efficacy of lamotrigine as an antiepileptic drug. Neurology1994;44(Suppl 8):29-35.
8.
Serra LL, Galliccho B., Serra FP, Rotondi F.: Calcium antagonists in the treatment of drug resistant epilepsy. J Neurol1994; 241(Suppl):544, Abstract.
9.
Köhr G., De Konink Y., Mody I.: Properties of NMDA-receptor channels in neurons acutely isolated from epileptic (kindled) rats. J Neurosci1993;13:3612-3627.
